These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16937506)

  • 1. Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy.
    Yuan JZ; Ye QF; Zhao LL; Ming YZ; Sun H; Zhu SH; Huang ZF; Wang MM
    World J Gastroenterol; 2006 Aug; 12(31):5055-9. PubMed ID: 16937506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperation risk factor analysis in orthotopic liver transplantation with pre-transplant artificial liver support therapy].
    Yuan JZ; Ye QF; Ming YZ; Hang ZF; Zhao LL; Zhao XY; Wang MM; Zhang MZ; Wen ZX; Zhu SH; Wu K
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):175-8. PubMed ID: 15760548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
    Donati G; La Manna G; Cianciolo G; Grandinetti V; Carretta E; Cappuccilli M; Panicali L; Iorio M; Piscaglia F; Bolondi L; Colì L; Stefoni S
    Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.
    Gaspari R; Avolio AW; Zileri Dal Verme L; Agnes S; Proietti R; Castagneto M; Gasbarrini A
    Transplant Proc; 2006 Dec; 38(10):3544-51. PubMed ID: 17175327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
    Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
    Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
    Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
    Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
    Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renal failure on liver transplantation survival.
    Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration.
    Liu YH; Wang Y; Yu LX; Sun LY; Feng BL; Shen ZY; Wang MM
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):316-7. PubMed ID: 15138135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Travaglia D; Guidi S; Novelli S; Lai Q; Morabito V; Berloco PB
    Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with a porcine hepatocyte-based liver support system.
    Chen SC; Hewitt WR; Watanabe FD; Eguchi S; Kahaku E; Middleton Y; Rozga J; Demetriou AA
    Int J Artif Organs; 1996 Nov; 19(11):664-9. PubMed ID: 8970834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mortality in orthotopic liver transplant recipients who require hemodialysis.
    Zand MS; Orloff MS; Abt P; Patel S; Tsoulfas G; Kashyap R; Jain A; Safadjou S; Bozorgzadeh A
    Clin Transplant; 2011; 25(2):213-21. PubMed ID: 20331690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation.
    Umphrey LG; Hurst RT; Eleid MF; Lee KS; Reuss CS; Hentz JG; Vargas HE; Appleton CP
    Liver Transpl; 2008 Jun; 14(6):886-92. PubMed ID: 18508373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL
    Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MARS (Molecular Adsorbent Recycling System) as a novel hepatic detoxification procedure until orthotopic liver transplantation].
    Ullerich H; Avenhaus W; Menzel J; Dietl KH; Domschke W; Lerch MM
    Z Gastroenterol; 2001 Dec; 39(12):1023-6. PubMed ID: 11753787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation.
    Esmat Gamil M; Pirenne J; Van Malenstein H; Verhaegen M; Desschans B; Monbaliu D; Aerts R; Laleman W; Cassiman D; Verslype C; Van Steenbergen W; Van Pelt J; Nevens F
    Transplant Proc; 2012 Nov; 44(9):2857-60. PubMed ID: 23146542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial liver support system in acute liver failure patients waiting liver transplantation.
    Montejo González JC; Catalán González M; Meneu Díaz JC; Moreno Elola-Olaso A; De la Cruz J; Moreno González E
    Hepatogastroenterology; 2009; 56(90):456-61. PubMed ID: 19579620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.